CAM
LXRX icon

Costello Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Costello Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-500
Closed -$1K – 227
2022
Q2 		$1K Hold
500
– – ﹤0.01% 222
2022
Q1 		$1K Hold
500
– – ﹤0.01% 235
2021
Q4 		$2K Buy
+500
New +$2.43K ﹤0.01% 224

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Costello Asset Management's LXRX Position: Q3 2022 in Review

Costello Asset Management sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2022, closing a stake of 500 shares — an estimated $1K sold.

Costello Asset Management first reported a position in LXRX in Q4 2021 and held it in 3 quarters. The position peaked at $2K in Q4 2021. 98 funds tracked by Wall St. Rank hold LXRX as of Q3 2022.

  • Costello Asset Management reported no remaining Lexicon Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Costello Asset Management sold 500 Lexicon Pharmaceuticals shares in Q3 2022, an estimated $1K.
  • Costello Asset Management first reported a position in Lexicon Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Costello Asset Management's Lexicon Pharmaceuticals position peaked at $2K in Q4 2021.
  • 98 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2022.

Based on Costello Asset Management's 13F filing for Q3 2022, filed 3 Nov 2022.